September 16, 2005 Statistical Methods for Testing Carcinogenic Potential of New Drugs in Animal Carcinogenicity Studies Hojin Moon, Ph.D. HMoonnctr.fda.gov.
meningitis
FDA Draft Guidance--Diabetes Mellitus--Developing Drugs and Therapeutic Biologics for Treatment and Prevention
Eclipse Test and Performance Tools Platform (TPTP)
ppt
Veritas Cluster Server-VCS
Managing Test Labs Without the Headaches
Bio Papers Leyden 1991
Evaluation of a potential mutagenic MOA based on analysis of the weight of evidence and using the modified Hill criteria Martha M. Moore, Ph.D. Director,
1 Issues in Selection of Deltas in Non-Inferiority Trials : Acute Bacterial Meningitis and Hospital- Acquired Pneumonia John H. Powers, M.D. Medical Officer.
